Clinical Trial Update: Exemestane With Celecoxib as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 neoadjuvant trial evaluating exemestane in combination with celecoxib in postmenopausal women with stage II–IV breast cancer; results were posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Aromasin (exemestane)
• CELEBREX (Celecoxib)

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-06-30